Metabolic Enzyme Triosephosphate Isomerase 1 and Nicotinamide Phosphoribosyltransferase, Two Independent Inflammatory Indicators in Rheumatoid Arthritis: Evidences From Collagen-Induced Arthritis and Clinical Samples

Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis (RA), while other metabolic regulators coordinating NAMPT to perpetuate inflammation are yet to be investigated. We continuously monitored and...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 12; p. 795626
Main Authors Lei, Ming, Tao, Meng-Qing, Wu, Yi-Jin, Xu, Liang, Yang, Zhe, Li, Yan, Olatunji, Opeyemi Joshua, Wang, Xiao-Wan, Zuo, Jian
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 17.01.2022
Subjects
Online AccessGet full text
ISSN1664-3224
1664-3224
DOI10.3389/fimmu.2021.795626

Cover

Abstract Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis (RA), while other metabolic regulators coordinating NAMPT to perpetuate inflammation are yet to be investigated. We continuously monitored and validated expression changes of Nampt and inflammatory indicators in peripheral while blood cells from rats with collagen-induced arthritis (CIA). Gene transcriptional profiles of Nampt + and Nampt ++ samples from identical CIA rats were compared by RNA-sequencing. Observed gene expression changes were validated in another batch of CIA rats, and typical metabolic regulators with persistent changes during inflammatory courses were further investigated in human subjects. According to expression differences of identified genes, RA patients were assigned into different subsets. Clinical manifestation and cytokine profiles among them were compared afterwards. Nampt overexpression typically occurred in CIA rats during early stages, when iNos and Il-1β started to be up-regulated. Among differentially expressed genes between Nampt + and Nampt ++ CIA rat samples, changes of Tpi1 , the only glycolytic enzyme identified were sustained in the aftermath of acute inflammation. Similar to NAMPT , TPI1 expression in RA patients was higher than general population, which was synchronized with increase in RFn as well as inflammatory monocytes-related cytokines like Eotaxin. Meanwhile, RANTES levels were relatively low when NAMPT and TPI1 were overexpressed. Reciprocal interactions between TPI1 and HIF-1α were observed. HIF-1α promoted TPI1 expression, while TPI1 co-localized with HIF-1α in nucleus of inflammatory monocytes. In short, although NAMPT and TPI1 dominate different stages of CIA, they similarly provoke monocyte-mediated inflammation.
AbstractList Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis (RA), while other metabolic regulators coordinating NAMPT to perpetuate inflammation are yet to be investigated. We continuously monitored and validated expression changes of Nampt and inflammatory indicators in peripheral while blood cells from rats with collagen-induced arthritis (CIA). Gene transcriptional profiles of Nampt+ and Nampt++ samples from identical CIA rats were compared by RNA-sequencing. Observed gene expression changes were validated in another batch of CIA rats, and typical metabolic regulators with persistent changes during inflammatory courses were further investigated in human subjects. According to expression differences of identified genes, RA patients were assigned into different subsets. Clinical manifestation and cytokine profiles among them were compared afterwards. Nampt overexpression typically occurred in CIA rats during early stages, when iNos and Il-1β started to be up-regulated. Among differentially expressed genes between Nampt+ and Nampt++ CIA rat samples, changes of Tpi1, the only glycolytic enzyme identified were sustained in the aftermath of acute inflammation. Similar to NAMPT, TPI1 expression in RA patients was higher than general population, which was synchronized with increase in RFn as well as inflammatory monocytes-related cytokines like Eotaxin. Meanwhile, RANTES levels were relatively low when NAMPT and TPI1 were overexpressed. Reciprocal interactions between TPI1 and HIF-1α were observed. HIF-1α promoted TPI1 expression, while TPI1 co-localized with HIF-1α in nucleus of inflammatory monocytes. In short, although NAMPT and TPI1 dominate different stages of CIA, they similarly provoke monocyte-mediated inflammation.Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis (RA), while other metabolic regulators coordinating NAMPT to perpetuate inflammation are yet to be investigated. We continuously monitored and validated expression changes of Nampt and inflammatory indicators in peripheral while blood cells from rats with collagen-induced arthritis (CIA). Gene transcriptional profiles of Nampt+ and Nampt++ samples from identical CIA rats were compared by RNA-sequencing. Observed gene expression changes were validated in another batch of CIA rats, and typical metabolic regulators with persistent changes during inflammatory courses were further investigated in human subjects. According to expression differences of identified genes, RA patients were assigned into different subsets. Clinical manifestation and cytokine profiles among them were compared afterwards. Nampt overexpression typically occurred in CIA rats during early stages, when iNos and Il-1β started to be up-regulated. Among differentially expressed genes between Nampt+ and Nampt++ CIA rat samples, changes of Tpi1, the only glycolytic enzyme identified were sustained in the aftermath of acute inflammation. Similar to NAMPT, TPI1 expression in RA patients was higher than general population, which was synchronized with increase in RFn as well as inflammatory monocytes-related cytokines like Eotaxin. Meanwhile, RANTES levels were relatively low when NAMPT and TPI1 were overexpressed. Reciprocal interactions between TPI1 and HIF-1α were observed. HIF-1α promoted TPI1 expression, while TPI1 co-localized with HIF-1α in nucleus of inflammatory monocytes. In short, although NAMPT and TPI1 dominate different stages of CIA, they similarly provoke monocyte-mediated inflammation.
Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis (RA), while other metabolic regulators coordinating NAMPT to perpetuate inflammation are yet to be investigated. We continuously monitored and validated expression changes of Nampt and inflammatory indicators in peripheral while blood cells from rats with collagen-induced arthritis (CIA). Gene transcriptional profiles of Nampt + and Nampt ++ samples from identical CIA rats were compared by RNA-sequencing. Observed gene expression changes were validated in another batch of CIA rats, and typical metabolic regulators with persistent changes during inflammatory courses were further investigated in human subjects. According to expression differences of identified genes, RA patients were assigned into different subsets. Clinical manifestation and cytokine profiles among them were compared afterwards. Nampt overexpression typically occurred in CIA rats during early stages, when iNos and Il-1β started to be up-regulated. Among differentially expressed genes between Nampt + and Nampt ++ CIA rat samples, changes of Tpi1 , the only glycolytic enzyme identified were sustained in the aftermath of acute inflammation. Similar to NAMPT , TPI1 expression in RA patients was higher than general population, which was synchronized with increase in RFn as well as inflammatory monocytes-related cytokines like Eotaxin. Meanwhile, RANTES levels were relatively low when NAMPT and TPI1 were overexpressed. Reciprocal interactions between TPI1 and HIF-1α were observed. HIF-1α promoted TPI1 expression, while TPI1 co-localized with HIF-1α in nucleus of inflammatory monocytes. In short, although NAMPT and TPI1 dominate different stages of CIA, they similarly provoke monocyte-mediated inflammation.
Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis (RA), while other metabolic regulators coordinating NAMPT to perpetuate inflammation are yet to be investigated. We continuously monitored and validated expression changes of Nampt and inflammatory indicators in peripheral while blood cells from rats with collagen-induced arthritis (CIA). Gene transcriptional profiles of Nampt+ and Nampt++ samples from identical CIA rats were compared by RNA-sequencing. Observed gene expression changes were validated in another batch of CIA rats, and typical metabolic regulators with persistent changes during inflammatory courses were further investigated in human subjects. According to expression differences of identified genes, RA patients were assigned into different subsets. Clinical manifestation and cytokine profiles among them were compared afterwards. Nampt overexpression typically occurred in CIA rats during early stages, when iNos and Il-1β started to be up-regulated. Among differentially expressed genes between Nampt+ and Nampt++ CIA rat samples, changes of Tpi1, the only glycolytic enzyme identified were sustained in the aftermath of acute inflammation. Similar to NAMPT, TPI1 expression in RA patients was higher than general population, which was synchronized with increase in RFn as well as inflammatory monocytes-related cytokines like Eotaxin. Meanwhile, RANTES levels were relatively low when NAMPT and TPI1 were overexpressed. Reciprocal interactions between TPI1 and HIF-1α were observed. HIF-1α promoted TPI1 expression, while TPI1 co-localized with HIF-1α in nucleus of inflammatory monocytes. In short, although NAMPT and TPI1 dominate different stages of CIA, they similarly provoke monocyte-mediated inflammation.
Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis (RA), while other metabolic regulators coordinating NAMPT to perpetuate inflammation are yet to be investigated. We continuously monitored and validated expression changes of and inflammatory indicators in peripheral while blood cells from rats with collagen-induced arthritis (CIA). Gene transcriptional profiles of and samples from identical CIA rats were compared by RNA-sequencing. Observed gene expression changes were validated in another batch of CIA rats, and typical metabolic regulators with persistent changes during inflammatory courses were further investigated in human subjects. According to expression differences of identified genes, RA patients were assigned into different subsets. Clinical manifestation and cytokine profiles among them were compared afterwards. overexpression typically occurred in CIA rats during early stages, when and started to be up-regulated. Among differentially expressed genes between and CIA rat samples, changes of , the only glycolytic enzyme identified were sustained in the aftermath of acute inflammation. Similar to , expression in RA patients was higher than general population, which was synchronized with increase in RFn as well as inflammatory monocytes-related cytokines like Eotaxin. Meanwhile, RANTES levels were relatively low when and were overexpressed. Reciprocal interactions between TPI1 and HIF-1α were observed. HIF-1α promoted expression, while TPI1 co-localized with HIF-1α in nucleus of inflammatory monocytes. In short, although NAMPT and TPI1 dominate different stages of CIA, they similarly provoke monocyte-mediated inflammation.
Author Xu, Liang
Zuo, Jian
Wang, Xiao-Wan
Wu, Yi-Jin
Li, Yan
Lei, Ming
Tao, Meng-Qing
Yang, Zhe
Olatunji, Opeyemi Joshua
AuthorAffiliation 2 Research Center of Integration of Traditional Chinese and Western Medicine, Wannan Medical College , Wuhu , China
4 Department of Traditional Chinese Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital) , Wuhu , China
5 Faculty of Traditional Thai Medicine, Prince of Songkla University , Hat Yai , Thailand
6 Key Laboratory of Non-coding RNA Transformation Research of Anhui Higher Education Institution, Wannan Medical College , Wuhu , China
1 Xin’an Medicine Research Center, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital) , Wuhu , China
3 Department of Rheumatology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital) , Wuhu , China
AuthorAffiliation_xml – name: 3 Department of Rheumatology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital) , Wuhu , China
– name: 5 Faculty of Traditional Thai Medicine, Prince of Songkla University , Hat Yai , Thailand
– name: 1 Xin’an Medicine Research Center, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital) , Wuhu , China
– name: 4 Department of Traditional Chinese Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital) , Wuhu , China
– name: 2 Research Center of Integration of Traditional Chinese and Western Medicine, Wannan Medical College , Wuhu , China
– name: 6 Key Laboratory of Non-coding RNA Transformation Research of Anhui Higher Education Institution, Wannan Medical College , Wuhu , China
Author_xml – sequence: 1
  givenname: Ming
  surname: Lei
  fullname: Lei, Ming
– sequence: 2
  givenname: Meng-Qing
  surname: Tao
  fullname: Tao, Meng-Qing
– sequence: 3
  givenname: Yi-Jin
  surname: Wu
  fullname: Wu, Yi-Jin
– sequence: 4
  givenname: Liang
  surname: Xu
  fullname: Xu, Liang
– sequence: 5
  givenname: Zhe
  surname: Yang
  fullname: Yang, Zhe
– sequence: 6
  givenname: Yan
  surname: Li
  fullname: Li, Yan
– sequence: 7
  givenname: Opeyemi Joshua
  surname: Olatunji
  fullname: Olatunji, Opeyemi Joshua
– sequence: 8
  givenname: Xiao-Wan
  surname: Wang
  fullname: Wang, Xiao-Wan
– sequence: 9
  givenname: Jian
  surname: Zuo
  fullname: Zuo, Jian
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35111160$$D View this record in MEDLINE/PubMed
BookMark eNp1UstuEzEUHaEiWko_gA3ykgUJnvF4HiyQqiiFSOUhCGvLjzuJK489tT1F4Uv5HDxJi1Ik7sK-8j0P6-o8z06ss5BlL3M8J6Rp33a678d5gYt8Xre0Kqon2VleVeWMFEV5ctSfZhch3OBUZUsIoc-yU0LzVBU-y35_gsiFM1qipf216wGtvXYBhq0Lw5ZHQKvgevA8AMoRtwp91tJFbXmvFaCve5jzWriwM9FzG7o9-A1a_3RoZRUMkA4bU98Z3vc8Or-bBlpObUDaom9bGKeBVujSx63XUYd3aHmXHKyEgK6869HCGcM3YGeJO0o4gu6_tTDaJkmDvvN-MBBeZE87bgJc3N_n2Y-r5XrxcXb95cNqcXk9k2VF46yupWhUUZFWUFFSoWjVCtxwSjnhXIqKyDpXDVVSYCWh40K0jWhqhZumULIj59nqoKscv2GD1z33O-a4ZvsH5zeM-6ilAUabSmKlatw2tBSAW8C1kCInNQeSU5y03h-0hlH0kOxs2qh5JPp4YvWWbdwdaxqc1-0k8PpewLvbEUJkvQ4S0uIsuDGwoipoUeEST9BXx15_TR6ikQD1ASC9C8FDx6SOPGo3WWvDcsymHLJ9DtmUQ3bIYWLm_zAfxP_P-QN7Culz
CitedBy_id crossref_primary_10_7717_peerj_14369
crossref_primary_10_1002_mnfr_202200429
crossref_primary_10_1002_ejlt_202200142
crossref_primary_10_3389_fphar_2022_830439
crossref_primary_10_1515_chem_2022_0249
crossref_primary_10_3389_fimmu_2024_1539317
crossref_primary_10_1016_j_phymed_2023_155132
crossref_primary_10_1111_bph_16360
crossref_primary_10_1007_s00011_023_01728_w
crossref_primary_10_2147_DDDT_S374827
crossref_primary_10_2147_DDDT_S397914
crossref_primary_10_2147_JIR_S508316
crossref_primary_10_2147_JIR_S378090
crossref_primary_10_1021_acsptsci_4c00470
crossref_primary_10_1093_rheumatology_kead390
crossref_primary_10_1016_j_ghres_2024_100003
crossref_primary_10_1186_s13075_025_03483_1
crossref_primary_10_2147_JIR_S474329
crossref_primary_10_3389_fphar_2024_1403823
crossref_primary_10_2147_JIR_S431600
Cites_doi 10.3389/fimmu.2019.02285
10.1038/nrrheum.2013.39
10.1007/s00216-016-9742-2
10.1038/cddis.2017.132
10.1126/science.1250684
10.1038/s41591-020-0939-8
10.1016/S0002-9440(10)61195-9
10.1038/s41385-020-00356-5
10.1371/journal.pone.0132695
10.2147/JIR.S295957
10.1016/j.jaut.2019.102400
10.1016/j.intimp.2021.107856
10.1155/2015/451319
10.3390/cells9081882
10.1007/s10753-020-01242-9
10.22141/2224-0721.13.1.2017.96762
10.3389/fmed.2018.00024
10.1097/BOR.0000000000000687
10.1007/s10753-018-0932-2
10.1093/rheumatology/keq266
10.3390/cells7100161
10.1007/s40744-019-00189-0
10.1242/dmm.034678
10.1111/imr.12838
10.4155/fmc.12.34
10.1016/j.humimm.2020.02.008
10.1002/art.1780380315
10.1093/rheumatology/kez344
10.1097/MD.0000000000002552
10.1016/j.nbd.2019.104575
10.1136/annrheumdis-2016-210713
10.1016/j.arcmed.2020.01.010
10.1007/s00296-020-04616-2
10.3389/fphar.2020.00197
10.1038/s41556-019-0287-4
10.1016/j.phrs.2018.06.022
10.1038/nrendo.2015.117
10.2147/JIR.S346365
ContentType Journal Article
Copyright Copyright © 2022 Lei, Tao, Wu, Xu, Yang, Li, Olatunji, Wang and Zuo.
Copyright © 2022 Lei, Tao, Wu, Xu, Yang, Li, Olatunji, Wang and Zuo 2022 Lei, Tao, Wu, Xu, Yang, Li, Olatunji, Wang and Zuo
Copyright_xml – notice: Copyright © 2022 Lei, Tao, Wu, Xu, Yang, Li, Olatunji, Wang and Zuo.
– notice: Copyright © 2022 Lei, Tao, Wu, Xu, Yang, Li, Olatunji, Wang and Zuo 2022 Lei, Tao, Wu, Xu, Yang, Li, Olatunji, Wang and Zuo
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3389/fimmu.2021.795626
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef


MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
ExternalDocumentID oai_doaj_org_article_586c0dd709854be09e07bcb137ae3150
PMC8801790
35111160
10_3389_fimmu_2021_795626
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
CGR
CUY
CVF
ECM
EIF
IAO
IEA
IHR
IHW
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c465t-77cb8d2639b5b45bd569b08a55a3aacb63c71d85dcb0dcefabb98b87d0882dcf3
IEDL.DBID M48
ISSN 1664-3224
IngestDate Wed Aug 27 01:24:23 EDT 2025
Thu Aug 21 18:28:03 EDT 2025
Thu Sep 04 19:53:57 EDT 2025
Thu Jan 02 22:54:52 EST 2025
Tue Jul 01 00:53:36 EDT 2025
Thu Apr 24 22:58:32 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords monocytes
nicotinamide phosphoribosyltransferase (NAMPT)
glycolysis
metabolism reprogramming
triosephosphate isomerase 1 (TPI1)
rheumatoid arthritis (RA)
collagen-induced arthritis (CIA)
Language English
License Copyright © 2022 Lei, Tao, Wu, Xu, Yang, Li, Olatunji, Wang and Zuo.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c465t-77cb8d2639b5b45bd569b08a55a3aacb63c71d85dcb0dcefabb98b87d0882dcf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Daniel Paul Heruth, Children’s Mercy Hospital, United States; Valentina Audrito, University of Turin, Italy
Edited by: Andras Perl, Upstate Medical University, United States
These authors have contributed equally to this work
This article was submitted to Autoimmune and Autoinflammatory Disorders, a section of the journal Frontiers in Immunology
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2021.795626
PMID 35111160
PQID 2625260400
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_586c0dd709854be09e07bcb137ae3150
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8801790
proquest_miscellaneous_2625260400
pubmed_primary_35111160
crossref_citationtrail_10_3389_fimmu_2021_795626
crossref_primary_10_3389_fimmu_2021_795626
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-01-17
PublicationDateYYYYMMDD 2022-01-17
PublicationDate_xml – month: 01
  year: 2022
  text: 2022-01-17
  day: 17
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2022
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Cheng (B23) 2014; 345
Yap (B5) 2018; 7
Yang (B18) 2019; 42
Grassi (B2) 2013; 9
Nacarelli (B35) 2019; 21
Stavropoulos-Kalinoglou (B9) 2011; 50
Repossi (B24) 2020; 51
Yang (B26) 2015; 10
Travelli (B15) 2018; 135
Scherer (B1) 2020; 110
Demizio (B6) 2020; 7
Ursini (B10) 2016; 95
Ogger (B30) 2021; 14
Conway (B31) 2018; 11
Singh (B34) 2020; 43
Alvandpur (B4) 2020; 81
Alivernini (B32) 2020; 26
Fu (B28) 2016; 408
Nikiphorou (B21) 2020; 59
Wyman (B13) 2020; 32
Zhang (B33) 2017; 8
Bukach (B7) 2017; 13
Weyand (B36) 2020; 294
von Meyenn (B38) 2019; 10
Garten (B14) 2015; 11
Wang (B19) 2021; 14
Wang (B17) 2021; 98
Wu (B20) 2005; 167
Nam (B3) 2017; 76
Dutta (B22) 2019; 132
Venetsanopoulou (B8) 2020; 40
Nowell (B16) 2012; 4
Soulaidopoulos (B25) 2018; 5
Li (B11) 2015; 2015
Kosgei (B29) 2020; 9
Hirohata (B37) 1995; 38
Zuo (B27) 2021; 14
Hua (B12) 2020; 11
References_xml – volume: 10
  year: 2019
  ident: B38
  article-title: Targeting T Cell Metabolism in Inflammatory Skin Disease
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.02285
– volume: 9
  year: 2013
  ident: B2
  article-title: Diagnosis of RA-We Have a Dream
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2013.39
– volume: 408
  year: 2016
  ident: B28
  article-title: Metabolomics Profiling of the Free and Total Oxidized Lipids in Urine by LC-MS/MS: Application in Patients With Rheumatoid Arthritis
  publication-title: Anal Bioanal Chem
  doi: 10.1007/s00216-016-9742-2
– volume: 8
  start-page: e2705
  year: 2017
  ident: B33
  article-title: Metabolic and Molecular Insights Into an Essential Role of Nicotinamide Phosphoribosyltransferase
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2017.132
– volume: 345
  start-page: 1250684
  year: 2014
  ident: B23
  article-title: mTOR- and HIF-1α-Mediated Aerobic Glycolysis as Metabolic Basis for Trained Immunity
  publication-title: Science
  doi: 10.1126/science.1250684
– volume: 26
  start-page: 1
  year: 2020
  ident: B32
  article-title: Distinct Synovial Tissue Macrophage Subsets Regulate Inflammation and Remission in Rheumatoid Arthritis
  publication-title: Nat Med
  doi: 10.1038/s41591-020-0939-8
– volume: 167
  year: 2005
  ident: B20
  article-title: Suppression of Matrix Metalloproteinase-9 by Prostaglandin E(2) in Peritoneal Macrophage is Associated With Severity of Endometriosis
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)61195-9
– volume: 14
  year: 2021
  ident: B30
  article-title: Macrophage Metabolic Reprogramming During Chronic Lung Disease
  publication-title: Mucosal Immunol
  doi: 10.1038/s41385-020-00356-5
– volume: 10
  start-page: e0132695
  year: 2015
  ident: B26
  article-title: Energy Metabolism Disorder as a Contributing Factor of Rheumatoid Arthritis: A Comparative Proteomic and Metabolomic Study
  publication-title: PloS One
  doi: 10.1371/journal.pone.0132695
– volume: 14
  start-page: 395
  year: 2021
  ident: B27
  article-title: Securidaca Inappendiculata-Derived Xanthones Protected Joints From Degradation in Male Rats With Collagen-Induced Arthritis by Regulating PPAR-γ Signaling
  publication-title: J Inflammation Res
  doi: 10.2147/JIR.S295957
– volume: 110
  start-page: 102400
  year: 2020
  ident: B1
  article-title: The Etiology of Rheumatoid Arthritis
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2019.102400
– volume: 98
  start-page: 107856
  year: 2021
  ident: B17
  article-title: Nicotinamide Mononucleotide-Elicited NAMPT Signaling Activation Aggravated Adjuvant-Induced Arthritis in Rats by Affecting Peripheral Immune Cells Differentiation
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2021.107856
– volume: 2015
  start-page: 451319
  year: 2015
  ident: B11
  article-title: Herb Network Analysis for a Famous TCM Doctor’s Prescriptions on Treatment of Rheumatoid Arthritis
  publication-title: Evid Based Complement Alternat Med
  doi: 10.1155/2015/451319
– volume: 9
  start-page: 1882
  year: 2020
  ident: B29
  article-title: Sirt1-PPARS Cross-Talk in Complex Metabolic Diseases and Inherited Disorders of the One Carbon Metabolism
  publication-title: Cells
  doi: 10.3390/cells9081882
– volume: 43
  year: 2020
  ident: B34
  article-title: Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation
  publication-title: Inflammation
  doi: 10.1007/s10753-020-01242-9
– volume: 13
  start-page: 79
  year: 2017
  ident: B7
  article-title: Changes of Lipid Metabolism in Patients With Rheumatoid Arthritis and Concomitant Arterial Hypertension, Abdominal Obesity and Diabetes Mellitus Type 2 Depending on the Gene Polymorphism T-786C of Endothelial Nitric Oxide Synthase
  publication-title: Int J Endocrinol
  doi: 10.22141/2224-0721.13.1.2017.96762
– volume: 5
  year: 2018
  ident: B25
  article-title: The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis
  publication-title: Front Med
  doi: 10.3389/fmed.2018.00024
– volume: 32
  year: 2020
  ident: B13
  article-title: Metabolic Pathways Mediate Pathogenesis and Offer Targets for Treatment in Rheumatic Diseases
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/BOR.0000000000000687
– volume: 42
  year: 2019
  ident: B18
  article-title: Metabolomics Analysis Reveals Therapeutic Effects of α-Mangostin on Collagen-Induced Arthritis in Rats by Down-Regulating Nicotinamide Phosphoribosyltransferase
  publication-title: Inflammation
  doi: 10.1007/s10753-018-0932-2
– volume: 50
  year: 2011
  ident: B9
  article-title: Obesity in Rheumatoid Arthritis
  publication-title: Rheumatol
  doi: 10.1093/rheumatology/keq266
– volume: 7
  start-page: 161
  year: 2018
  ident: B5
  article-title: Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development
  publication-title: Cells
  doi: 10.3390/cells7100161
– volume: 7
  start-page: 19
  year: 2020
  ident: B6
  article-title: Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis
  publication-title: Rheumatol Ther
  doi: 10.1007/s40744-019-00189-0
– volume: 11
  start-page: 034678
  year: 2018
  ident: B31
  article-title: Bone Marrow Transplantation Corrects Haemolytic Anaemia in a Novel ENU Mutagenesis Mouse Model of TPI Deficiency
  publication-title: Dis Model Mech
  doi: 10.1242/dmm.034678
– volume: 294
  year: 2020
  ident: B36
  article-title: Immunometabolism in the Development of Rheumatoid Arthritis
  publication-title: Immunol Rev
  doi: 10.1111/imr.12838
– volume: 4
  year: 2012
  ident: B16
  article-title: PBEF/NAMPT/visfatin: A Promising Drug Target for Treating Rheumatoid Arthritis
  publication-title: Future Med Chem
  doi: 10.4155/fmc.12.34
– volume: 81
  year: 2020
  ident: B4
  article-title: Circulating IFN-γ Producing CD4+ T Cells and IL-17A Producing CD4+ T Cells, HLA-Shared Epitope and ACPA may Characterize the Clinical Response to Therapy in Rheumatoid Arthritis Patients
  publication-title: Hum Immunol
  doi: 10.1016/j.humimm.2020.02.008
– volume: 38
  year: 1995
  ident: B37
  article-title: Selective Induction of IgM Rheumatoid Factors by CD14+ Monocyte-Lineage Cells Generated From Bone Marrow of Patients With Rheumatoid Arthritis
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.1780380315
– volume: 59
  start-page: 997
  year: 2020
  ident: B21
  article-title: Haematological Abnormalities in New-Onset Rheumatoid Arthritis and Risk of Common Infections: A Population-Based Study
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kez344
– volume: 95
  start-page: e2552
  year: 2016
  ident: B10
  article-title: Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: An OGTT Study
  publication-title: Medicine
  doi: 10.1097/MD.0000000000002552
– volume: 132
  start-page: 104575
  year: 2019
  ident: B22
  article-title: RANTES-Induced Invasion of Th17 Cells Into Substantia Nigra Potentiates Dopaminergic Cell Loss in MPTP Mouse Model of Parkinson's Disease
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2019.104575
– volume: 76
  year: 2017
  ident: B3
  article-title: Efficacy of Biological Disease-Modifying Antirheumatic Drugs: A Systematic Literature Review Informing the 2016 Update of the EULAR Recommendations for the Management of Rheumatoid Arthritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2016-210713
– volume: 51
  year: 2020
  ident: B24
  article-title: Molecular Basis of the Beneficial Actions of Resveratrol
  publication-title: Arch Med Res
  doi: 10.1016/j.arcmed.2020.01.010
– volume: 40
  year: 2020
  ident: B8
  article-title: The Lipid Paradox in Rheumatoid Arthritis: The Dark Horse of the Augmented Cardiovascular Risk
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-020-04616-2
– volume: 11
  year: 2020
  ident: B12
  article-title: Pulsatilla Decoction can Treat the Dampness-Heat Diarrhea Rat Model by Regulating Glycerinphospholipid Metabolism Based Lipidomics Approach
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2020.00197
– volume: 21
  start-page: 397
  year: 2019
  ident: B35
  article-title: NAD+ Metabolism Governs the Proinflammatory Senescence-Associated Secretome
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-019-0287-4
– volume: 135
  start-page: 25
  year: 2018
  ident: B15
  article-title: NAMPT: A Pleiotropic Modulator of Monocytes and Macrophages
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2018.06.022
– volume: 11
  year: 2015
  ident: B14
  article-title: Physiological and Pathophysiological Roles of NAMPT and NAD Metabolism
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2015.117
– volume: 14
  year: 2021
  ident: B19
  article-title: Qing-Luo-Yin Alleviated Experimental Arthritis in Rats by Disrupting Immune Feedback Between Inflammatory T Cells and Monocytes: Key Evidences From Its Effects on Immune Cell Phenotypes
  publication-title: J Inflammation Res
  doi: 10.2147/JIR.S346365
SSID ssj0000493335
Score 2.4135478
Snippet Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 795626
SubjectTerms Animals
Arthritis, Experimental
Arthritis, Rheumatoid - diagnosis
Arthritis, Rheumatoid - etiology
Arthritis, Rheumatoid - metabolism
Biomarkers
collagen-induced arthritis (CIA)
Computational Biology - methods
Cytokines - genetics
Cytokines - metabolism
Disease Models, Animal
Disease Susceptibility
Gene Expression
Gene Expression Profiling
glycolysis
Humans
Hypoxia-Inducible Factor 1, alpha Subunit - metabolism
Immunology
Inflammation Mediators - metabolism
Macrophage Activation - genetics
Macrophage Activation - immunology
Macrophages - immunology
Macrophages - metabolism
metabolism reprogramming
monocytes
Nicotinamide Phosphoribosyltransferase - genetics
Nicotinamide Phosphoribosyltransferase - metabolism
Prognosis
Rats
rheumatoid arthritis (RA)
Triose-Phosphate Isomerase - genetics
Triose-Phosphate Isomerase - metabolism
triosephosphate isomerase 1 (TPI1)
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9NAFB5kQfBFvFtvjOCTGHcmk8kkvqls2RVWRLuwb2FupVmaZElSpP5Sf47nTNKSiuiLb6Vz0h5yvsycb87kO4S88hZWGW9Z5Hi8jBIleJRLPCMG_FYl1nMl8N3h88_p6UXy6VJeTlp94ZmwQR54uHHHMkstc07BxTIxnuWeKWMNF0p7MbJ1lrMJmboa8l4hhBzKmMDC8uNlWVUb4IMxf6uAE6CYwmQhCnr9f0oyfz8rOVl85nfI7TFrpO8Hb--SG76-R24OfSS398nPc99DMNelpSf1j23l6aItw9Z-012vIJukZ12Du0-dp5zq2lEEQF9iM3rn6Zdg1rSlabrtug-pbDB-QxffG3q275Tbw-clQKgKpXkcwB2_pu1oWdOvK7_BgdKhn6sglvSO7rqWdnTeNhXFfQqYweoIW4ZYPzENbo0qpWv6TaNqcfeAXMxPFh9Po7FlQ2STVPaQq1uTuRjSHiNNIo2TaW5YpqXUQmtrUmEVd5l01jC4pUttTJ6ZTDnM9J1diofkqG5q_5jQWCmYjjKtMh8nwsscfk9rp3IsFAHLmxG2i19hRz1zbKuxLoDXYMiLEPICQ14MIZ-R1_tLrgcxj78Zf0BQ7A1Rhzt8AegsRnQW_0LnjLzcQaqA5xaLMbr2zaYrYiCewCVhCp2RRwPE9n-FxV3OUxhRB-A78OVwpC5XQRscpmPUXHvyP5x_Sm7F-LIH4xFXz8hR3278c0jBevMiPG2_AH3MNY0
  priority: 102
  providerName: Directory of Open Access Journals
Title Metabolic Enzyme Triosephosphate Isomerase 1 and Nicotinamide Phosphoribosyltransferase, Two Independent Inflammatory Indicators in Rheumatoid Arthritis: Evidences From Collagen-Induced Arthritis and Clinical Samples
URI https://www.ncbi.nlm.nih.gov/pubmed/35111160
https://www.proquest.com/docview/2625260400
https://pubmed.ncbi.nlm.nih.gov/PMC8801790
https://doaj.org/article/586c0dd709854be09e07bcb137ae3150
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ti9NAEF7OE8Ev4vvV02MFP4k5s0k2mwgiKlfvhBPRFvot7FtspEnukhStv9Sf48wmLVcpgl9CyE7SbWZ295mZzTyEPLMaVhmrfc-wIPciETIv5bhHDPxbEWnLRIjfDp9_ik-n0ccZn-2RNb3V8ALbna4d8klNm8Xxz8vVGxjwr9HjhPX2ZV6U5RJcvYAdC4D7QXyNXHfpItzJN6D97z0YDkNHucniOPLAlKM-z7n7KVsrlSvovwuF_r2Z8srqNL5Nbg2wkr7t7eAO2bPVXXKjJ5pc3SO_z20H2l4Ump5Uv1alpZOmcLH_ur2YA9ykZ22N4anWUkZlZShaSFcgW72x9LMTq5tC1e1q0Tms64Rf0MmPmp5tqHQ7OM_BxkqXu8cGDAnWTUuLin6Z2yU2FAb7OXfVlF7RNa1pS8dNXVIMZMAUV3nIKaLtFVHXraGM6YJ-lVjWuL1PpuOTyftTb-B08HQU8w7AvFaJCQAXKa4irgyPU-UnknMZSqlVHGrBTMKNVj680lwqlSYqEQZdAaPz8AHZr-rKHhAaCAHzVSJFYoMotDyF50lpRIqZJHADR8Rf6y_TQ8Fz5N1YZOD4oMozp_IMVZ71Kh-R55tbLvpqH_8SfodGsRHEQt3uQt18y4Zxn_Ek1r4xAmyfR8r6qfWF0oqFQtoQwPiIPF2bVAYDG7M1srL1ss0C8EzB2YQ5dkQe9ia2-SnM_jIWQ4vYMr6tvmy3VMXcFQ-H-RqLsj36n396SG4G-NWHzzwmHpP9rlnaJ4DFOnXkYhhw_DBjR260_QGnDTle
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolic+Enzyme+Triosephosphate+Isomerase+1+and+Nicotinamide+Phosphoribosyltransferase%2C+Two+Independent+Inflammatory+Indicators+in+Rheumatoid+Arthritis%3A+Evidences+From+Collagen-Induced+Arthritis+and+Clinical+Samples&rft.jtitle=Frontiers+in+immunology&rft.au=Lei%2C+Ming&rft.au=Tao%2C+Meng-Qing&rft.au=Wu%2C+Yi-Jin&rft.au=Xu%2C+Liang&rft.date=2022-01-17&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=12&rft_id=info:doi/10.3389%2Ffimmu.2021.795626&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fimmu_2021_795626
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon